AGE-RAGE Signaling in Diabetes and Its Vascular Complications: Molecular Mechanisms and Therapeutic Perspectives: A Review of Current Literature

Advanced Glycation End products (AGEs) are formed through non-enzymatic interactions between reducing sugars and cellular macromolecules, a process substantially enhanced under sustained hyperglycemic and oxidative stress conditions. Under normal physiology, AGEs are detoxified by the glyoxalase system; however, their pathological accumulation is closely linked to aging, diabetes mellitus, and associated metabolic disorders. The biological effects of AGEs are primarily mediated through binding to the Receptor for Advanced Glycation End products (RAGE), which activates downstream signalling pathways that promote oxidative stress, inflammatory responses, immune dysfunction, and metabolic imbalance. Insulin resistance, a central feature of diabetes, results from the combined influence of obesity, chronic hyperinsulinemia, and cellular stress, leading to disruption of Insulin Receptor Substrate-1 (IRS-1) signalling. Persistent hyperglycemia further aggravates metabolic dysregulation by enhancing protein glycation and stimulating the hexosamine biosynthetic pathway, thereby increasing Reactive Oxygen Species (ROS) generation. Excessive ROS impairs pancreatic β-cell integrity by altering redox homeostasis and essential cellular processes. Diabetes mellitus is increasingly recognised as a systemic vascular disorder affecting both microvascular and macrovascular networks, resulting in complications involving the nervous system, kidneys, heart, brain, and major arteries. Aberrant activation of signalling molecules such as ERK, JNK, IKKβ, PKCβ, PKC zeta, and mTOR contributes to defective insulin signalling and secretion. Advanced Glycation End products (AGEs) accumulate under chronic hyperglycemic and oxidative stress conditions and contribute to metabolic dysfunction by activating the RAGE signalling pathway. This activation promotes oxidative stress, inflammation, and impaired insulin signalling, leading to insulin resistance and β-cell damage. Consequently, persistent hyp

View article page

Download PDF